Journal
JOURNAL OF THORACIC DISEASE
Volume 10, Issue -, Pages S1864-S1870Publisher
AME PUBL CO
DOI: 10.21037/jtd.2018.03.151
Keywords
Thermal therapy; non-small cell lung cancer (NSCLC); early stage; alternative treatment
Categories
Ask authors/readers for more resources
The mainstream treatment modality for early stage non-small cell lung cancer (NSCLC) is surgery; however, many patients are deemed inoperable and warrant alternative therapeutic options. Several minimally invasive catheter-based therapies are emerging as viable alternatives. In this review, we evaluate the outcomes from radiofrequency ablation (RFA), microwave ablation (MWA), cryoablation (CRA) and photodynamic therapy (PDT) for early-stage lung cancer. Novel technical developments have allowed for endobronchial thermal ablation to be conducted in a hybrid theatre setting, which may optimize treatment outcomes and minimise treatment-related complications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available